Cargando…
Zinc cooperates with p53 to inhibit the activity of mitochondrial aconitase through reactive oxygen species accumulation
Metabolic reprogramming is a central hallmark of cancer. Therefore, targeting metabolism may provide an effective strategy for identifying promising drug targets for cancer treatment. In prostate cancer, cells undergo metabolic transformation from zinc‐accumulating, citrate‐producing cells to citrat...
Autores principales: | Xue, Ya‐Nan, Liu, Ya‐Nan, Su, Jing, Li, Jiu‐Ling, Wu, Yao, Guo, Rui, Yu, Bing‐Bing, Yan, Xiao‐Yu, Zhang, Li‐Chao, Sun, Lian‐Kun, Li, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536939/ https://www.ncbi.nlm.nih.gov/pubmed/30972978 http://dx.doi.org/10.1002/cam4.2130 |
Ejemplares similares
-
Inhibition of Mitochondrial Aconitase by Succination in Fumarate Hydratase Deficiency
por: Ternette, Nicola, et al.
Publicado: (2013) -
Zinc shapes the folding landscape of p53 and establishes a pathway for reactivating structurally diverse cancer mutants
por: Blanden, Adam R, et al.
Publicado: (2020) -
Cooperation of SRPK2, Numb and p53 in the malignant biology and chemosensitivity of colorectal cancer
por: Wang, Guosen, et al.
Publicado: (2020) -
Mitochondrial aconitase suppresses immunity by modulating oxaloacetate and the mitochondrial unfolded protein response
por: Kim, Eunah, et al.
Publicado: (2023) -
Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues
por: Singh, Keshav K, et al.
Publicado: (2006)